Asset Management One
SUPN icon

Asset Management One’s Supernus Pharmaceuticals SUPN Stock Holding History

Asset Management One’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-38,560
Closed -$954K – 1190
2016
Q3 		$954K Buy
38,560
+13,720
+55% +$311K 0.01% 867
2016
Q2 		$506K Sell
24,840
-15,727
-39% -$279K 0.01% 1046
2016
Q1 		$619K Hold
40,567
– – 0.01% 1017
2015
Q4 		$545K Buy
40,567
+22,016
+119% +$341K 0.01% 1050
2015
Q3 		$260K Hold
18,551
– – ﹤0.01% 1184
2015
Q2 		$315K Buy
+18,551
New +$264K ﹤0.01% 1185

Other funds holding SUPN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Asset Management One's SUPN Position: Q4 2016 in Review

Asset Management One sold out of Supernus Pharmaceuticals (SUPN) in Q4 2016, closing a stake of 38,560 shares — an estimated $954K sold.

Asset Management One first reported a position in SUPN in Q2 2015 and held it in 6 quarters. The position peaked at $954K in Q3 2016. 233 funds tracked by Wall St. Rank hold SUPN as of Q4 2016.

  • Asset Management One reported no remaining Supernus Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 38,560 Supernus Pharmaceuticals shares in Q4 2016, an estimated $954K.
  • Asset Management One first reported a position in Supernus Pharmaceuticals in Q2 2015 and held it in 6 quarters.
  • Asset Management One's Supernus Pharmaceuticals position peaked at $954K in Q3 2016.
  • 233 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.